Wednesday, October 7, 2015

Warren Buffett: Johnson & Johnson 'messed up in a lot of ways'

Billionaire and investing icon Warren Buffett said that health-care giant Johnson & Johnson has "obviously messed up in a lot of ways in the last few years."

Warren Buffett: Johnson & Johnson 'messed up in a lot of ways'

Warren Buffett
Warren Buffett

Billionaire and investing icon Warren Buffett said Monday morning that health-care giant Johnson & Johnson has "obviously messed up in a lot of ways in the last few years."

Buffett is chairman of Berkshire Hathaway, Co., the investment company that owns or holds sizable positions in companies in numerous industries, J&J, Wells Fargo and Coca-Cola among them.

"They have some wonderful products and a wonderful balance sheet, but too many mistakes have been made at Johnson & Johnson," Buffett said in the interview with CNBC's Becky Quick on the show Squawk Box. "Clearly, they have not lived up to their standards."

Buffett had a mixed view of J&J's stock, which has lagged compared to competitors.

More coverage
CEO Bill Weldon to retire in April at Johnson & Johnson

Buffett said Berkshire has not sold its stake but "we might," although there is no need to because Berkshire already sits on plenty of cash.

"If I needed money, that would be on my sell list" versus Wells Fargo and others in the portfolio, Buffett said.

Buffett's comments come on the heals of last week's change in leadership. The company said Alex Gorsky will replace Bill Weldon as chief executive officer in April.

Nonetheless, the J&J board gave Weldon an extra bonus from what he got in 2010. The 2010 compensation was about $28 million.

Sunday's Inquirer story presented some of the challenges ahead for Gorsky. That story is here.

Inquirer Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at or 215-854-4506.

David Sell Inquirer Staff Writer
Also on
letter icon Newsletter